Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Drug Discovery Today
|
December 28, 2023
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
Wenzhan Yang, Sugandha Saboo, Liping Zhou, et al.
Molecular Pharmaceutics
|
June 24, 2018
The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles
Sean Askin, Min Zhao, Andrea D Gonçalves, et al.
Molecular Pharmaceutics
|
October 19, 2020
A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions
Sean Askin, Andrea D Gonçalves, Min Zhao, et al.
International Journal of Pharmaceutics
|
December 21, 2021
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca
Akosua B Anane-Adjei, Esther Jacobs, Samuel C Nash, et al.
International Journal of Pharmaceutics
|
February 26, 2017
The application of novel nano-thermal and imaging techniques for monitoring drug microstructure and distribution within PLGA microspheres
Fan Yang, De Chen, Zhe-Fei Guo, et al.
Molecular Pharmaceutics
|
October 2, 2025
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement
Martin A Screen, Sean Askin, James F McCabe, et al.
Crystal Growth & Design
|
October 20, 2025
Nonmimetic Gels Direct Novel Crystallization Behavior of Lenalidomide
Martin A Screen, Juan A Aguilar, Toby J Blundell, et al.
Journal of the American Chemical Society
|
July 23, 2025
Crystallizing the Uncrystallizable: Insights from Extensive Screening of PROTACs
Martin A Screen, James F McCabe, Sean Askin, et al.
Archives of Toxicology
|
May 16, 2024
Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition
Valentina Fogal, Filippos Michopoulos, Andrew F Jarnuczak, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Drug Discovery Today
|
December 28, 2023
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
Wenzhan Yang, Sugandha Saboo, Liping Zhou, et al.
Molecular Pharmaceutics
|
June 24, 2018
The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles
Sean Askin, Min Zhao, Andrea D Gonçalves, et al.
Molecular Pharmaceutics
|
October 19, 2020
A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions
Sean Askin, Andrea D Gonçalves, Min Zhao, et al.
International Journal of Pharmaceutics
|
December 21, 2021
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca
Akosua B Anane-Adjei, Esther Jacobs, Samuel C Nash, et al.
International Journal of Pharmaceutics
|
February 26, 2017
The application of novel nano-thermal and imaging techniques for monitoring drug microstructure and distribution within PLGA microspheres
Fan Yang, De Chen, Zhe-Fei Guo, et al.
Molecular Pharmaceutics
|
October 2, 2025
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement
Martin A Screen, Sean Askin, James F McCabe, et al.
Crystal Growth & Design
|
October 20, 2025
Nonmimetic Gels Direct Novel Crystallization Behavior of Lenalidomide
Martin A Screen, Juan A Aguilar, Toby J Blundell, et al.
Journal of the American Chemical Society
|
July 23, 2025
Crystallizing the Uncrystallizable: Insights from Extensive Screening of PROTACs
Martin A Screen, James F McCabe, Sean Askin, et al.
Archives of Toxicology
|
May 16, 2024
Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition
Valentina Fogal, Filippos Michopoulos, Andrew F Jarnuczak, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Page
of 1